Results 251 to 260 of about 222,357 (321)

Precision Stealth Nanofibers via PET‐RAFT Polymerisation: Synthesis, Crystallization‐driven Self‐assembly and Cellular Uptake Studies

open access: yesChemistry – A European Journal, EarlyView.
Stealth polymer nanofibers are promising therapeutic delivery systems that suffer from challenging functionalization. In this work we harness photoinduced electron/energy transfer reversible addition–fragmentation chain transfer (PET‐RAFT) polymerisation and crystallization‐driven self‐assembly (CDSA) to produce low length‐dispersity poly ...
Steven T. G. Street   +6 more
wiley   +1 more source

Replacing a Cereblon Ligand by a DDB1 and CUL4 Associated Factor 11 (DCAF11) Recruiter Converts a Selective Histone Deacetylase 6 PROTAC into a Pan‐Degrader

open access: yesChemMedChem, EarlyView.
This study introduced DCAF11 as an E3 ligase for PROTAC‐mediated histone deacetylase (HDAC) degradation. By replacing cereblon with DCAF11 as recruited E3 ligase, a selective HDAC6 degrader (A6) was transformed into pan‐HDAC degraders. The lead compound, 1j (FF2039), potently degraded HDACs from classes I, IIa, and IIb, showing strong antiproliferative
Felix Feller   +5 more
wiley   +1 more source

The intrinsic radioresistance of glioblastoma-derived cell lines is associated with a failure of p53 to induce p21 BAX expression

open access: green, 1998
Hui‐Kuo G. Shu   +5 more
openalex   +1 more source

Neoadjuvant chemotherapy plus anlotinib in the treatment of resectable head and neck squamous cell carcinoma: A pilot phase II trial

open access: yes
Cancer Communications, EarlyView.
Qianting He   +11 more
wiley   +1 more source

Boron in My Mind: A Comprehensive Review of the Evolution of the Diverse Syntheses of 4‐Borono‐l‐Phenylalanine, the Leading Agent for Boron Neutron Capture Therapy

open access: yesChemMedChem, EarlyView.
Boron Neutron Capture Therapy is a promising technique for treating “untreatable” brain cancers by having 10B nuclei absorb neutrons and then decay to 7Li destroying the cells they are in. The dominant clinical agent is 4‐borono‐l‐phenylalanine, and this review comprehensively analyzes all of its reported patent and literature syntheses to help ...
Sarfraz Ahmad   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy